Lipid-Based Nanotherapeutics for Inflammatory Disorders: Current Progress and Future Perspectives.
Aberrant inflammatory responses are crucial indicators of the onset and progression of diverse pathologies, including metabolic syndromes, autoimmune disorders, and neuroinflammation. The intrinsic intricacy and heterogeneity of these signaling pathways require innovative therapeutic approaches that allow precise immun...